Peptide record

TPDB24246

Peptide 2b Antibacterial Anticancer Antidiabetic Antifungal modified_plain modified
2 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB24246
Peptide 2b
Antibacterial Anticancer Antidiabetic Antifungal
Anti-infective peptides Cardiometabolic peptides Cancer-related peptides
Peptipedia CancerPPD 2.0
modified_plain
Yes
A 2-aa modified multi-activity (Antibacterial, Anticancer, Antidiabetic, and other sources) peptide sequence curated from Peptipedia and CancerPPD 2.0, with an available 3D structural model.
N-terminal: 4-azidobenzoic acid
Sequence
PE
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
2 reviewed residue count
Free Activity
L Activity
Linear Activity
4-azidobenzoic acid Activity
Antiproliferative, Anticancer Activity
Synthetic Activity
Evidence Records 4 records
Evidence 1 Activity

Activity

IC50
IC50 = 12.1 ± 0.23 µM
Anticancer
12.1

Target

Breast Cancer
MCF-7
Breast

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2017

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50 = 19.3 ± 0.02 µM
Anticancer
19.3

Target

Liver Cancer
HepG-2
Liver

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2017
Evidence 3 Activity

Activity

IC50
IC50 = 19.9 ± 0.03 µM
Anticancer
19.9

Target

Lung Cancer
A-549
Lung

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2017
Evidence 4 Activity

Activity

IC50
IC50 = 17.7 ± 0.04 µM
Anticancer
17.7

Target

Cervical Cancer
HeLa
Cervix

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2017